Vanda posted a GAAP net loss of USD 62.5 million, widening from USD 27.2 million a year earlier; diluted loss per share widened to USD 1.04.
Total revenues slipped 3.92% to USD 50.53 million, as Fanapt net product sales rose 23% to USD 36 million while HETLIOZ net product sales fell 66% to USD 5.58 million.
Loss before income taxes widened to USD 62.38 million from USD 34.89 million, reflecting continued investment in new product launches and pipeline advancement.
Cash totaled USD 170 million at June 30, down USD 32.3 million in the quarter; resources expected to fund operations through at least end-2027.
Reiterated 2026 total revenue guidance of USD 240 million to USD 290 million; BYSANTI launch expected in the second half, Quimilza PDUFA set for Dec. 12.
VNDA•
